Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dejan Krajcar
Observed name:
Krajcar, Dejan
Institution:
University of Ljubljana
Observed institutions:
University of Ljubljana,
Sandoz Group AG (Switzerland)
ORCID:
0000-0002-4774-1450
Observed ORCID:
0000-0002-4774-1450
OpenAlex ID:
A5082156419
The biorelevant simulation of gastric emptying and its impact on model drug dissolution and absorption kinetics
2020
·
Helena Vrbanac
, Jurij Trontelj
, et al.
·
European Journal of Pharmaceutics and Biopharmaceutics
·
31
Determining the Polymer Threshold Amount for Achieving Robust Drug Release from HPMC and HPC Matrix Tablets Containing a High-Dose BCS Class I Model Drug: In Vitro and In Vivo Studies
2014
·
Uroš Klančar
, Saša Baumgartner
, et al.
·
AAPS PharmSciTech
·
30
PDF
Advancing Virtual Bioequivalence for Orally Administered Drug Products: Methodology, Real-World Applications and Future Outlook
2024
·
Sivacharan Kollipara
, Frederico Severino Martins
, et al.
·
Pharmaceuticals
·
25
PDF
Predictive Potential of BCS and Pharmacokinetic Parameters on Study Outcome: Analysis of 198 In Vivo Bioequivalence Studies
2023
·
Dejan Krajcar
, Iztok Grabnar
, et al.
·
European Journal of Drug Metabolism and Pharmacokinetics
·
10
PDF
Predictive Potential of Acido-Basic Properties, Solubility and Food on Bioequivalence Study Outcome: Analysis of 128 Studies
2023
·
Dejan Krajcar
, Rebeka Jereb
, et al.
·
Drugs in R&D
·
6
PDF
Simulated migrating motor complex and its impact on the release properties of hydrophilic matrix systems
2019
·
Helena Vrbanac
, Jurij Trontelj
, et al.
·
Journal of Drug Delivery Science and Technology
·
6
Machine learning driven bioequivalence risk assessment at an early stage of generic drug development
2024
·
Dejan Krajcar
, Dejan Velušček
, et al.
·
European Journal of Pharmaceutics and Biopharmaceutics
·
1
Show more works
View as search
Works count:
9
Citation count:
109
H-index:
6
I10-index:
4
Year
Topic
Type